CClinicalTrials.gg
Active, not recruitingNCT03405116PRETURNUpdated May 30, 2024

Prediction Tool for Premature Labour and Neonatal Outcome

An observational study in Premature Birth, sponsored by University Hospital, Ghent. Active, not recruiting at 1 site in Belgium. Open to participants aged 18 Years to 50 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-30.

Sponsored by University Hospital, Ghent · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
2,037
Ages
18 Years to 50 Years
Sex
All
01

Study summary

A register and prediction model will be developed to predict the outcome of preterm labour and birth.

02

Conditions studied

  • Premature Birth

Browse trials for

03

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Women visiting the maternity ward suffering from symptoms of preterm birth.

Inclusion criteria

  • Gestational age of 24 weeks 0 days and 33 weeks and 6 days, and their preterm born children

Exclusion criteria

Exclusion Criteria:

  • Patients who choose not to participate in the research.
  • Intra-uterine prelabour fetal death.
  • Fetuses or neonates with a major congenital disorder. Major is defined as a disorder that has an impact on neonatal respiratory and cerebral outcome and/or long-term outcome.
  • Postpartum transfer/outborn.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
2,037 participants (actual)
Target follow-up
4 Years
Patient registry
Yes
05

What researchers measure

Primary outcomes

  1. Register

    A multicentre, multidisciplinary register will be created to provide a source of valuable information on obstetrical and neonatal practices and link them with obstetrical, neonatal and long-term outcomes of preterm labour and birth

    Time frame: 2017 - 2030

  2. Prediction model

    The prediction tool for true preterm labour (TPL) will be developed using individual risk factors, symptomatology, tocography, cervical change and a biomarker test, followed by a decision-making model, both based on individual data, evidence and experience.

    Time frame: 2017 - 2030

Secondary outcomes

  1. The interval between starting corticosteroids and delivery

    The interval between administration of antenatal corticosteroids and birth will be assessed and will be related to the short and long term outcome of preterm born children

    Time frame: 2012-2020

06

Study locations

1 site
  • Ghent University Hospital - Women's Clinic
    Ghent, 9000, Belgium
07

References and documents

Publications

  • Dehaene I, Scheire E, Steen J, De Coen K, Decruyenaere J, Smets K, Roelens K. Obstetrical characteristics and neonatal outcome according to aetiology of preterm birth: a cohort study. Arch Gynecol Obstet. 2020 Oct;302(4):861-871. doi: 10.1007/s00404-020-05673-5. Epub 2020 Jul 3. PubMed 32621250 ↗

Individual participant data

Plan to share: Undecided

08

Registry details

Key details

Study ID
NCT03405116
Lead sponsor
University Hospital, Ghent
Responsible party
Sponsor
First posted
Jan 19, 2018
Start date
Jul 1, 2017
Primary completion
May 1, 2023
Completion
Dec 2032 (estimated)
Last update
May 30, 2024

Study contacts

Kristien Roelens, MD, PhD
principal investigator · University Hospital, Ghent
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion